WFA
LKFT

Wipfli Financial Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Wipfli Financial Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Buy
+4
New +$205 ﹤0.01% 2577

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Wipfli Financial Advisors's LKFT Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2022: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2577 among its holdings.

84 funds tracked by Wall St. Rank hold LKFT as of Q3 2022.

  • Wipfli Financial Advisors held 4 shares of Lakefront Biotherapeutics American Depositary Shares worth $0 as of Q3 2022.
  • Lakefront Biotherapeutics American Depositary Shares was a new Wipfli Financial Advisors position in Q3 2022.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2577 holding.
  • 84 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.